The Smartest Dividend Stocks to Buy With $500 Right Now

The article argues that Progressive, Wells Fargo, and Accenture are stronger fundamental businesses than their recent stock weakness suggests, with all three offering attractive dividend yields. Progressive reported 16% revenue growth in 2025, underwriting margin expansion to 12.6%, and net income rising to $11.3 billion, while Wells Fargo posted Q4 revenue up a little more than 4% and Q1 revenue up more than 6%, with EPS of $1.62 and $1.60, respectively. Accenture generated nearly $70 billion in revenue last year, up 7%, and expects FY earnings of $13.52-$13.90, supported by a dividend that has been raised for 21 consecutive years.

Analysis

The common thread is not “cheap defensive stocks,” but franchises where the market has over-penalized near-term estimate noise while the underlying cash-generating machine is still compounding. That matters because once rate volatility and growth-stock leadership fade, investors usually rotate first into names with visible earnings power and then into names with credible capital return policies; all three here fit that profile to different degrees. The second-order effect is that capital may migrate away from crowded duration beneficiaries and into financially resilient operators that can self-fund buybacks/dividends without relying on multiple expansion.

Progressive is the highest-quality operating story here, but the setup is tricky: a big headline yield can attract income capital that does not understand the payout is highly front-loaded and thus mechanically unstable year to year. The more interesting angle is that underwriting discipline, not premium growth, is what preserves upside if claims inflation cools; if loss costs stabilize over the next 2-3 quarters, consensus is likely still too low on normalized ROE. The risk is that any renewed severity pressure or adverse weather cluster would hit the stock twice — via earnings and via a narrative reset on durability.

Wells Fargo is a cleaner “prove it” trade: the business is demonstrating modest but real operating leverage, yet the market is still treating it like a damaged asset with a permanent valuation discount. If asset-cap removal is finally being absorbed by the market, the next leg is less about revenue acceleration and more about buybacks plus dividend growth compounding per-share EPS over the next 4-6 quarters. Accenture is the most contrarian name: the selloff appears to assume IT/services demand is structurally impaired, but AI implementation and enterprise workflow outsourcing are exactly the kind of budget items companies keep funding even in a softer macro, making the current drawdown more likely a sentiment overcorrection than a fundamental break.

Key Decisions for Investors

• Long PGR on any further weakness; target a 6-12 month holding period. Risk/reward favors upside if loss-cost inflation decelerates, but size modestly because the payout is lumpy and claims severity can reset earnings quickly.
• Buy WFC as a value-plus-capital-return compounder over the next 3-6 months. The valuation is still too cheap for a bank with improving operating momentum; downside is a continued multiple trap if execution disappoints again, so keep position size below core financials exposure until another clean quarter prints.
• Initiate ACN as a contrarian long for 6-9 months. The stock likely benefits if enterprises continue funding AI and productivity projects even in a slower economy; pair against a more cyclically exposed consulting/services name if you want to isolate resilience premium.
• Consider a pair trade long ACN / short a higher-beta IT services peer or short a software/services basket into any sector bounce. The thesis is that the market is still overpricing cyclical demand risk in ACN relative to its recurring enterprise-spend profile.
• For income-oriented accounts, prefer WFC over PGR on current yield quality and payout durability. PGR can work as a total-return trade, but WFC offers a cleaner combination of valuation support and a more predictable distribution path.